Aspirin on par with dalteparin in preventing VTE after hip replacement

06/4/2013 | Medscape (free registration)

Aspirin performed comparably to dalteparin in preventing venous thromboembolism following total hip arthroplasty, according to a 778-patient study in the Annals of Internal Medicine. There were no major bleeding events in the group given aspirin, while there was one case in the dalteparin group. Clinically significant nonmajor bleeding and minor bleeding were reported more often in the dalteparin group than the aspirin group.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Catheter Engineer Manager
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Director, Office of Compliance
FDA, Center for Devices and Radiological Health
Silver Spring, MD